See more : StreamPlay Studio Limited (SP8.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Sensus Healthcare, Inc. (SRTS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sensus Healthcare, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Storebrand ASA (SREDY) Income Statement Analysis – Financial Results
- Twelve Seas Investment Company II (TWLV) Income Statement Analysis – Financial Results
- CIFI Ever Sunshine Services Group Limited (1995.HK) Income Statement Analysis – Financial Results
- Meituan (3690.HK) Income Statement Analysis – Financial Results
- ATN International Limited (ATNINTER.NS) Income Statement Analysis – Financial Results
Sensus Healthcare, Inc. (SRTS)
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 24.41M | 44.53M | 27.04M | 9.58M | 27.26M | 26.43M | 20.59M | 14.81M | 10.27M | 5.81M | 10.48M |
Cost of Revenue | 10.35M | 14.90M | 10.05M | 4.33M | 9.71M | 9.52M | 6.79M | 4.97M | 3.70M | 2.05M | 3.60M |
Gross Profit | 14.06M | 29.63M | 16.99M | 5.25M | 17.56M | 16.91M | 13.80M | 9.85M | 6.57M | 3.76M | 6.88M |
Gross Profit Ratio | 57.61% | 66.53% | 62.82% | 54.81% | 64.40% | 63.99% | 67.03% | 66.48% | 64.00% | 64.63% | 65.64% |
Research & Development | 3.68M | 3.46M | 3.44M | 4.16M | 6.42M | 6.26M | 5.49M | 1.82M | 1.47M | 1.58M | 1.33M |
General & Administrative | 5.16M | 5.01M | 4.59M | 3.99M | 4.00M | 4.12M | 3.72M | 3.47M | 1.59M | 1.65M | 1.45M |
Selling & Marketing | 5.61M | 6.33M | 4.84M | 5.34M | 9.10M | 8.53M | 8.31M | 4.92M | 3.74M | 4.21M | 3.97M |
SG&A | 10.76M | 11.34M | 9.43M | 9.33M | 13.11M | 12.66M | 12.03M | 8.38M | 5.33M | 5.86M | 5.42M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 14.44M | 14.80M | 12.87M | 13.48M | 19.53M | 18.92M | 17.52M | 10.21M | 6.80M | 7.44M | 6.75M |
Cost & Expenses | 24.79M | 29.70M | 22.92M | 17.81M | 29.23M | 28.43M | 24.31M | 15.17M | 10.49M | 9.49M | 10.35M |
Interest Income | 992.00K | 382.00K | 2.00K | 52.56K | 268.29K | 139.28K | 75.81K | 38.54K | 1.78K | 820.00 | 1.25K |
Interest Expense | 0.00 | 2.00K | 1.00K | 14.23K | 0.00 | 156.69K | 68.88K | 21.87K | 17.79K | 20.03K | 20.47K |
Depreciation & Amortization | 461.00K | 315.00K | 613.00K | 721.87K | 545.72K | 658.26K | 387.92K | 337.58K | 315.60K | 272.65K | 265.56K |
EBITDA | 79.00K | 14.83M | 4.73M | -6.10M | -1.15M | -1.21M | -3.25M | 13.00K | 96.12K | -3.41M | 393.65K |
EBITDA Ratio | 0.32% | 34.16% | 15.24% | -100.03% | -6.24% | -7.06% | -17.69% | -2.19% | 0.94% | -58.63% | 3.76% |
Operating Income | -382.00K | 14.83M | 4.12M | -8.23M | -1.97M | -2.01M | -3.72M | -363.12K | -221.26K | -3.68M | 126.84K |
Operating Income Ratio | -1.57% | 33.30% | 15.24% | -85.98% | -7.22% | -7.59% | -18.06% | -2.45% | -2.15% | -63.34% | 1.21% |
Total Other Income/Expenses | 1.03M | 13.16M | -1.00K | 1.40M | 268.29K | -17.41K | 6.93K | 16.67K | -16.01K | -19.21K | -19.21K |
Income Before Tax | 652.00K | 27.99M | 4.12M | -6.84M | -1.70M | -2.02M | -3.71M | -346.45K | -237.27K | -3.70M | 107.63K |
Income Before Tax Ratio | 2.67% | 62.85% | 15.23% | -71.37% | -6.24% | -7.65% | -18.02% | -2.34% | -2.31% | -63.67% | 1.03% |
Income Tax Expense | 167.00K | 3.75M | -613.00K | -2.12M | -545.72K | 139.28K | -312.11K | -299.05K | 1.78K | 820.00 | 1.25K |
Net Income | 485.00K | 24.24M | 4.12M | -4.72M | -1.15M | -2.02M | -3.71M | -346.45K | -237.27K | -3.70M | 107.63K |
Net Income Ratio | 1.99% | 54.44% | 15.23% | -49.24% | -4.23% | -7.65% | -18.02% | -2.34% | -2.31% | -63.67% | 1.03% |
EPS | 0.03 | 1.47 | 0.25 | -0.29 | -0.07 | -0.14 | -0.28 | -0.03 | -0.02 | -0.37 | -0.04 |
EPS Diluted | 0.03 | 1.46 | 0.25 | -0.29 | -0.07 | -0.14 | -0.28 | -0.03 | -0.02 | -0.37 | -0.04 |
Weighted Avg Shares Out | 16.26M | 16.48M | 16.48M | 16.43M | 16.23M | 14.12M | 13.24M | 12.03M | 10.78M | 9.88M | 9.79M |
Weighted Avg Shares Out (Dil) | 16.27M | 16.62M | 16.50M | 16.43M | 16.23M | 14.12M | 13.24M | 12.03M | 10.78M | 9.89M | 9.89M |
Sensus Healthcare, Inc (SRTS) Q2 2023 Earnings Call Transcript
Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Misses Revenue Estimates
Sensus Healthcare Reports Second Quarter 2023 Financial Results
Sensus Healthcare to Host Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 3, 2023
Sensus Healthcare Completes Installation of its First SRT System in Ireland
7 Undervalued Stocks Ready for a Bounce Back
Sensus Healthcare (SRTS) Expands Global Base With New Pact
Sensus Healthcare Partners with MIS Healthcare to Distribute SRT Systems in the United Kingdom and Ireland
3 Under-$10 Sleeper Stocks to Buy Before Investors Wake Up
Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Misses Revenue Estimates
Source: https://incomestatements.info
Category: Stock Reports